NCT06789614View on ClinicalTrials.gov

Comparison of the Effect of Cyclizine Versus Metoclopramide on Gastric Residual Volume in Patients Undergoing Bariatric Surgery: A Randomized Double-blinded Clinical Trial

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 18, 2025

Primary Completion Date

September 18, 2025

Study Completion Date

October 18, 2025

Conditions

Bariatric Surgery

Interventions

DRUG

intravenous CYCLIZINE ,Metaclopromide

US giuded measure of GRV in bariatrics surgery upon recieving drugs of study

All Listed Sponsors

lead

Cairo University

OTHER

NCT06789614 - Comparison of the Effect of Cyclizine Versus Metoclopramide on Gastric Residual Volume in Patients Undergoing Bariatric Surgery: A Randomized Double-blinded Clinical Trial | Biotech Hunter | Biotech Hunter